secwatch.observer — SEC 8-K summary
======================================

Issuer:     CDT Equity Inc. (CDT)
CIK:        0001896212
Form:       8-K/A
Filed at:   2023-10-05T23:59:59+00:00
Accession:  0001493152-23-036388
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.01, 5.02, 2.01, 5.06, 9.01, 3.02, 3.01, 3.03, 5.03, 5.01, 5.05, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Conduit Pharmaceuticals completes business combination with Murphy Canyon Acquisition Corp.
--------------------------------------------------------------------------------

- Business Combination closed on Sept 22, 2023; MURF renamed to Conduit Pharmaceuticals Inc.
- 65M shares of common stock issued as merger consideration to Old Conduit holders.
- PIPE Financing of $20M from Nirland Limited for 2M units at $10/unit.
- Approximately 2.13M public shares redeemed at ~$10.84 per share from trust.
- Andrew Regan beneficially owns 62.9% of outstanding shares post-combination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1896212/000149315223036388/0001493152-23-036388-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1896212/000149315223036388/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-036388

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer